Zortea, K.; Franco, V.C.; Francesconi, L.P.; Cereser, K.M.M.; Lobato, M.I.R.; Belmonte-de-Abreu, P.S.
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors. Nutrients 2016, 8, 73.
https://doi.org/10.3390/nu8020073
AMA Style
Zortea K, Franco VC, Francesconi LP, Cereser KMM, Lobato MIR, Belmonte-de-Abreu PS.
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors. Nutrients. 2016; 8(2):73.
https://doi.org/10.3390/nu8020073
Chicago/Turabian Style
Zortea, Karine, Viviane C. Franco, Lenise P. Francesconi, Keila M. M. Cereser, Maria Inês R. Lobato, and Paulo S. Belmonte-de-Abreu.
2016. "Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors" Nutrients 8, no. 2: 73.
https://doi.org/10.3390/nu8020073
APA Style
Zortea, K., Franco, V. C., Francesconi, L. P., Cereser, K. M. M., Lobato, M. I. R., & Belmonte-de-Abreu, P. S.
(2016). Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors. Nutrients, 8(2), 73.
https://doi.org/10.3390/nu8020073
